BIO stock · rev $651.0M

BIO (BIO) common stock.

Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.

Use this BIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BIO SEC filings page. Lician reads the product cache first so this HTML stays unique to BIO even when a live quote feed is slow.

BIO latest statements (FY2025)

Latest cached year on this hub. Full BIO income, balance, and cash tables.

  • Revenue$2.58B
  • Net Income$759.9M
  • Total Assets$10.58B
  • Total Debt$1.21B
  • Free Cash Flow$374.6M